<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
    <title>oncolab_blog</title>
    <link rel="alternate" type="text/html" href="http://www.oncolabinc.com/blog/" />
    <link rel="self" type="application/atom+xml" href="http://www.oncolabinc.com/blog/atom.xml" />
    <id>tag:www.oncolabinc.com,2009-09-27:/blog//1</id>
    <updated>2010-03-24T19:57:29Z</updated>
    
    <generator uri="http://www.sixapart.com/movabletype/">Movable Type 4.31-en</generator>

<entry>
    <title>Reovirus study for prostate cancer</title>
    <link rel="alternate" type="text/html" href="http://www.oncolabinc.com/blog/2010/03/post.html" />
    <id>tag:www.oncolabinc.com,2010:/blog//1.26</id>

    <published>2010-03-10T17:07:48Z</published>
    <updated>2010-03-24T19:57:29Z</updated>

    <summary><![CDATA[A study by Don G. Morris, MD, PhD of the Tom Baker Cancer Center showed that reovirus did in fact have a substantial effect on prostate cancer cells.&nbsp; Although Dr. Morris said there are downsides, as a whole the study...]]></summary>
    <author>
        <name>Paul Navitsky</name>
        <uri>http://www.oncolabinc.com</uri>
    </author>
    
        <category term="General information" scheme="http://www.sixapart.com/ns/types#category" />
    
    
    <content type="html" xml:lang="en-US" xml:base="http://www.oncolabinc.com/blog/">
        <![CDATA[A study by Don G. Morris, MD, PhD of the Tom Baker Cancer Center showed that reovirus did in fact have a substantial effect on prostate cancer cells.&nbsp; Although Dr. Morris said there are downsides, as a whole the study was quite successful.&nbsp; Reovirus can potentially be combined with chemotherapy or other therapies to mitigate these issues.&nbsp; Not only can reovirus destroy cancer cells but can also cause an immune system response in the area of the tumor.<br /><br />A full article can be found here:<br /><a href="http://www.webmd.com/cancer/news/20100309/tumor-melting-virus-vs-prostate-cancer" target="_blank">http://www.webmd.com/cancer/news/20100309/tumor-melting-virus-vs-prostate-cancer</a><br /><div><br /></div>]]>
        
    </content>
</entry>

<entry>
    <title>CT scans may pose cancer risk, new research indicates</title>
    <link rel="alternate" type="text/html" href="http://www.oncolabinc.com/blog/2010/03/ct-scans-may-pose-cancer-risk-new-research-indicates.html" />
    <id>tag:www.oncolabinc.com,2010:/blog//1.25</id>

    <published>2010-03-08T16:14:23Z</published>
    <updated>2010-03-24T19:57:54Z</updated>

    <summary><![CDATA[The Chicago Tribune posted an article about the risks of CT scans which is quite informative.&nbsp; CT scans while a powerful tools for diagnosing a wide range of diseases has the potential to cause problems as well.Although the AMAS test...]]></summary>
    <author>
        <name>Paul Navitsky</name>
        <uri>http://www.oncolabinc.com</uri>
    </author>
    
        <category term="General information" scheme="http://www.sixapart.com/ns/types#category" />
    
    
    <content type="html" xml:lang="en-US" xml:base="http://www.oncolabinc.com/blog/">
        <![CDATA[The Chicago Tribune posted an article about the risks of CT scans which is quite informative.&nbsp; CT scans while a powerful tools for diagnosing a wide range of diseases has the potential to cause problems as well.<br />Although the AMAS test is not by itself diagnostic of the presence or absence of disease, it can be used as an aid to diagnosis, detection or monitoring of disease.&nbsp; Since the AMAS test is non-invasive, in some cases it can be used for screening rather that CT scans which can lessen the exposure to potentially harmful radiation.<br /><br />The full article can be found here:<br /><a href="http://www.chicagotribune.com/health/ct-met-radiation-exposure-20100307,0,619847.story" target="_blank">http://www.chicagotribune.com/health/ct-met-radiation-exposure-20100307,0,619847.story</a><br /><div><br /></div>]]>
        
    </content>
</entry>

<entry>
    <title>Colorectal Cancer Awareness Month</title>
    <link rel="alternate" type="text/html" href="http://www.oncolabinc.com/blog/2010/03/colorectal-cancer-awareness-month.html" />
    <id>tag:www.oncolabinc.com,2010:/blog//1.24</id>

    <published>2010-03-04T19:03:41Z</published>
    <updated>2010-03-24T19:58:25Z</updated>

    <summary><![CDATA[March is colorectal cancer awareness month.&nbsp; Information about the risks, when to start screening and the types of screening can be found at the links below.&nbsp; http://www.cdc.gov/features/colorectalawareness/http://www.bcm.edu/news/item.cfm?newsID=1841...]]></summary>
    <author>
        <name>Paul Navitsky</name>
        <uri>http://www.oncolabinc.com</uri>
    </author>
    
        <category term="General information" scheme="http://www.sixapart.com/ns/types#category" />
    
    
    <content type="html" xml:lang="en-US" xml:base="http://www.oncolabinc.com/blog/">
        <![CDATA[March is colorectal cancer awareness month.&nbsp; Information about the risks, when to start screening and the types of screening can be found at the links below.&nbsp; <br /><br /><a href="http://www.cdc.gov/features/colorectalawareness/">http://www.cdc.gov/features/colorectalawareness/</a><br /><br /><a href="http://www.bcm.edu/news/item.cfm?newsID=1841" target="_blank">http://www.bcm.edu/news/item.cfm?newsID=1841</a><br /> <div><br /></div><div><br /></div>]]>
        
    </content>
</entry>

<entry>
    <title>Symptoms May Do Little to Improve Early Detection of Ovarian Cancer</title>
    <link rel="alternate" type="text/html" href="http://www.oncolabinc.com/blog/2010/02/symptoms-may-do-little-to-improve-early-detection-of-ovarian-cancer.html" />
    <id>tag:www.oncolabinc.com,2010:/blog//1.23</id>

    <published>2010-02-09T14:50:28Z</published>
    <updated>2010-02-09T18:06:54Z</updated>

    <summary><![CDATA[An interesting article was recently posted on CancerConsultants.com about ovarian cancer and how the symptoms are not particularly helpful in its early detection.&nbsp; In 2000 an article was published in Cancer Detection and Prevention about the link between Anti-Malignin Antibody...]]></summary>
    <author>
        <name>Paul Navitsky</name>
        <uri>http://www.oncolabinc.com</uri>
    </author>
    
        <category term="General information" scheme="http://www.sixapart.com/ns/types#category" />
    
    
    <content type="html" xml:lang="en-US" xml:base="http://www.oncolabinc.com/blog/">
        <![CDATA[An interesting article was recently posted on <a href="http://www.cancerconsultants.com/" target="_blank">CancerConsultants.com</a> about ovarian cancer and how the symptoms are not particularly helpful in its early detection.&nbsp; In 2000 an article was published in Cancer Detection and Prevention about the link between Anti-Malignin Antibody and ovarian cancer and more importantly how it can be used for early detection.&nbsp; The AMAS test looks for this antibody in the blood and has been shown to be more sensitive than the CA125 test.<br /><br />Both articles can be found at the links below:<br /><a href="http://www.cancerconsultants.com/symptoms-improve-early-detection-ovarian-cancer/" target="_blank">http://www.cancerconsultants.com/symptoms-improve-early-detection-ovarian-cancer/</a><br /><a href="http://www.oncolabinc.com/paper.php?id=CancerDet_Prev.Antibody.2000.pdf" target="_blank">http://www.oncolabinc.com/paper.php?id=CancerDet_Prev.Antibody.2000.pdf</a><br /> <div><br /></div><div><br /></div>]]>
        
    </content>
</entry>

<entry>
    <title>World Cancer Day 2010</title>
    <link rel="alternate" type="text/html" href="http://www.oncolabinc.com/blog/2010/02/world-cancer-day-2010.html" />
    <id>tag:www.oncolabinc.com,2010:/blog//1.22</id>

    <published>2010-02-01T14:58:23Z</published>
    <updated>2010-02-01T15:45:45Z</updated>

    <summary><![CDATA[February 4th marks the fifth year of the World Cancer Day which is lead by The International Union Against Cancer (UICC)&nbsp; Each year focuses on a different initiative, this year's being&nbsp; "Cancer can be prevented too".&nbsp; More information can be...]]></summary>
    <author>
        <name>Paul Navitsky</name>
        <uri>http://www.oncolabinc.com</uri>
    </author>
    
        <category term="General information" scheme="http://www.sixapart.com/ns/types#category" />
    
    
    <content type="html" xml:lang="en-US" xml:base="http://www.oncolabinc.com/blog/">
        <![CDATA[February 4th marks the fifth year of the World Cancer Day which is lead by The International Union Against Cancer (UICC)&nbsp; Each year focuses on a different initiative, this year's being&nbsp;<span> "Cancer can be prevented too".&nbsp; <br /><br /></span>More information can be found here: <br /><a href="http://www.worldcancercampaign.org/">http://www.worldcancercampaign.org/</a><br /><div><br /></div>]]>
        
    </content>
</entry>

<entry>
    <title>Mammography availability linked to breast cancer mortality rate</title>
    <link rel="alternate" type="text/html" href="http://www.oncolabinc.com/blog/2010/01/mammography-availability-linked-to-breast-cancer-mortality-rate.html" />
    <id>tag:www.oncolabinc.com,2010:/blog//1.20</id>

    <published>2010-01-12T15:32:29Z</published>
    <updated>2010-01-12T16:57:00Z</updated>

    <summary><![CDATA[Dr. Kandace Klein of the Medical College of Georgia has linked the breast cancer mortality rate to the availability of mammograms.&nbsp; While Mammograms are typically seen as the best cancer screening tests there are downsides.&nbsp; Mammograms are quite intrusive and...]]></summary>
    <author>
        <name>Paul Navitsky</name>
        <uri>http://www.oncolabinc.com</uri>
    </author>
    
        <category term="General information" scheme="http://www.sixapart.com/ns/types#category" />
    
    
    <content type="html" xml:lang="en-US" xml:base="http://www.oncolabinc.com/blog/">
        <![CDATA[Dr. Kandace Klein of the Medical College of Georgia has linked the breast cancer mortality rate to the availability of mammograms.&nbsp; While Mammograms are typically seen as the best cancer screening tests there are downsides.&nbsp; Mammograms are quite intrusive and painful.&nbsp; By no means do we suggest that the AMAS test is a replacement for mammograms but the AMAS test can be used along side standard cancer screening tools to increase the possibility of spotting a malignancy in the early stages. <br /><br />The full article can be found here:<br /><a href="http://www.eurekalert.org/pub_releases/2010-01/mcog-mal011110.php">http://www.eurekalert.org/pub_releases/2010-01/mcog-mal011110.php</a><br /><div><br /></div>]]>
        
    </content>
</entry>

<entry>
    <title>MRI Screening Refused by Many Women at Risk for Breast Cancer</title>
    <link rel="alternate" type="text/html" href="http://www.oncolabinc.com/blog/2010/01/many-women-at-increased-risk-of-breast-cancer-refuse-mri-screening.html" />
    <id>tag:www.oncolabinc.com,2010:/blog//1.18</id>

    <published>2010-01-05T17:51:22Z</published>
    <updated>2010-01-06T16:01:53Z</updated>

    <summary>CancerConsultants.com (an informational cancer website) posted an article citing an American College of Radiology Imaging Network study that found approximately 58% of women with a high risk of breast cancer agreed to a MRI screen while the remainder refused for...</summary>
    <author>
        <name>Paul Navitsky</name>
        <uri>http://www.oncolabinc.com</uri>
    </author>
    
        <category term="General information" scheme="http://www.sixapart.com/ns/types#category" />
    
    
    <content type="html" xml:lang="en-US" xml:base="http://www.oncolabinc.com/blog/">
        <![CDATA[CancerConsultants.com (an informational cancer website) posted an article citing an <span class="articleText" xmlns:xs="http://www.w3.org/2001/XMLSchema">American College of Radiology Imaging Network</span> study that found approximately 58% of women with a high risk of breast cancer agreed to a MRI screen while the remainder refused for a variety of reasons.&nbsp; <br />]]>
        <![CDATA[Many of the reasons women refused the screening are mitigated by AMAS
screening.&nbsp; Primarily, there were issues related directly to the
technology behind MRI's, <span class="articleText" xmlns:xs="http://www.w3.org/2001/XMLSchema">claustrophobia, </span>"<span class="articleText" xmlns:xs="http://www.w3.org/2001/XMLSchema">medically intolerant to MR imaging", and </span><span class="articleText" xmlns:xs="http://www.w3.org/2001/XMLSchema">because of the need for intravenous injection.</span>&nbsp;
Yet another reason for women refusing the MRI was financial reasons,
the AMAS test is inexpensive when compared to MRI's.<br />
<br />
Read the entire article from CancerConsultants.com here:<br /><a href="http://professional.cancerconsultants.com/oncology_main_news.aspx?id=44451" target="_blank">http://professional.cancerconsultants.com/oncology_main_news.aspx?id=44451</a><br /><div><br /><b>About the AMAS Cancer test</b><br />The AMAS test is a non-invasive screening tool. From a blood sample, a specific antibody (called Anti-Malignin Antibody) can be measured to determine if there is any response from the immune system to several types of cancers in different parts of the body, including breast cancer. <br /><br />While the test cannot be used to determine the location of the tumor or cancer, it has been proven useful for doctors as a screening and diagnostic tool for over two decades.<br /><br />Learn more about the AMAS test <a href="http://www.oncolabinc.com/about.php" target="_blank">here</a> <br /></div>]]>
    </content>
</entry>

<entry>
    <title>Oncolab and AnyLabTestNow </title>
    <link rel="alternate" type="text/html" href="http://www.oncolabinc.com/blog/2010/01/oncolab-and-anylabtestnow.html" />
    <id>tag:www.oncolabinc.com,2010:/blog//1.17</id>

    <published>2010-01-04T14:49:35Z</published>
    <updated>2010-01-04T15:52:50Z</updated>

    <summary><![CDATA[An update of our previous entries pertaining to AnyLabTestNow draw sites.&nbsp; We have since received several more contracts from the following locations:...]]></summary>
    <author>
        <name>Paul Navitsky</name>
        <uri>http://www.oncolabinc.com</uri>
    </author>
    
        <category term="News" scheme="http://www.sixapart.com/ns/types#category" />
    
    
    <content type="html" xml:lang="en-US" xml:base="http://www.oncolabinc.com/blog/">
        <![CDATA[An update of our previous entries pertaining to AnyLabTestNow draw sites.&nbsp; We have since received several more contracts from the following locations:<br /><br />]]>
        <![CDATA[Charlotte NC<br />North Charlotte NC<br /><a href="http://anylabtestnow.com/rdu">Raleigh-Durham NC</a><br /><a href="http://www.anylabtestnow.com/cosprings">Colorado Springs CO</a><br /><a href="http://www.anylabtestnow.com/Hallandale_FL.aspx">Hallandale FL</a><br /><a href="http://www.anylabtestrosenberg.com/">Rosenberg TX</a><br /><a href="http://www.anylabtestnow.com/sugar_land">Sugar Land TX</a><br /><a href="http://www.anylabtestnow.com/lasvegas">Las Vegas NV</a><br /><br />]]>
    </content>
</entry>

<entry>
    <title>Holiday Hours</title>
    <link rel="alternate" type="text/html" href="http://www.oncolabinc.com/blog/2009/12/holiday-hours.html" />
    <id>tag:www.oncolabinc.com,2009:/blog//1.16</id>

    <published>2009-12-23T13:53:02Z</published>
    <updated>2009-12-23T13:54:57Z</updated>

    <summary><![CDATA[Oncolab will be closed Thursday December 24th, Friday December 25th and Friday January 1st.&nbsp; Oncolab wishes everyone Happy Holidays.&nbsp;...]]></summary>
    <author>
        <name>Paul Navitsky</name>
        <uri>http://www.oncolabinc.com</uri>
    </author>
    
        <category term="News" scheme="http://www.sixapart.com/ns/types#category" />
    
    <category term="oncolabholidayhourschristmasclosed" label="oncolab holiday hours christmas closed" scheme="http://www.sixapart.com/ns/types#tag" />
    
    <content type="html" xml:lang="en-US" xml:base="http://www.oncolabinc.com/blog/">
        <![CDATA[Oncolab will be closed Thursday December 24th, Friday December 25th and Friday January 1st.&nbsp; Oncolab wishes everyone Happy Holidays.&nbsp; ]]>
        
    </content>
</entry>

<entry>
    <title>AMAS Draw Sites</title>
    <link rel="alternate" type="text/html" href="http://www.oncolabinc.com/blog/2009/11/amas-draw-sites.html" />
    <id>tag:www.oncolabinc.com,2009:/blog//1.15</id>

    <published>2009-11-11T13:39:24Z</published>
    <updated>2009-11-12T15:28:37Z</updated>

    <summary><![CDATA[Oncolab has been working diligently for the past several months to sign up official draw sites to perform the AMAS draw.&nbsp; As posted earlier, we have started to sign AnyLabTestNow sites and thus far we have received fourteen contracts:&nbsp;...]]></summary>
    <author>
        <name>Paul Navitsky</name>
        <uri>http://www.oncolabinc.com</uri>
    </author>
    
        <category term="News" scheme="http://www.sixapart.com/ns/types#category" />
    
    <category term="labblooddrawanylabtestnowamastest" label="Lab blood draw anylabtestnow AMAS test" scheme="http://www.sixapart.com/ns/types#tag" />
    
    <content type="html" xml:lang="en-US" xml:base="http://www.oncolabinc.com/blog/">
        <![CDATA[Oncolab has been working diligently for the past several months to sign up official draw sites to perform the AMAS draw.&nbsp; As posted earlier, we have started to sign AnyLabTestNow sites and thus far we have received fourteen contracts:&nbsp; ]]>
        <![CDATA[<a href="http://www.anylabtestorangecity.com/" target="_blank">Orange City FL</a><br /><a href="http://anylabsorlando.com/" target="_blank">Orlando FL</a><br /><a href="http://www.anylabtestnow.com/Lakeland" target="_blank">Lakeland FL</a><br /><a href="http://www.anylabtestnow.com/Metairie_LA" target="_blank">Metairie LA</a><br /><a href="http://www.anylabtestnow.com/Shreveport_LA" target="_blank">Shreveport LA</a><br /><a href="http://www.anylabtestnow.com/Lafayette_LA" target="_blank">Lafayete LA</a><br /><a href="http://www.anylabtestnow.com/BatonRouge_LA" target="_blank">Baton Rouge LA</a><br /><a href="http://www.anylabtestnow.com/Killeen" target="_blank">Harker Heights TX</a><br /><a href="http://www.anylabtestnow.com/Abilene_TX.aspx" target="_blank">Abilene TX</a><br /><a href="http://www.anylabtestnowcincy.com/" target="_blank">Cincinnati OH</a><br /><a href="http://www.anylabtestnow.com/Lexington" target="_blank">Lexington KY</a><br /><a href="http://www.anylabtestnow.com/Englewood" target="_blank">Denver CO</a><br /><div><a href="http://www.anylabtestnow.com/Merrimack" target="_blank">Merrimack NH</a></div><div><br /></div>]]>
    </content>
</entry>

<entry>
    <title>AnyLabTestNow Locations Now Signing to be Official Draw Sites</title>
    <link rel="alternate" type="text/html" href="http://www.oncolabinc.com/blog/2009/10/anylabtestnow-locations-now-signing-to-be-official-draw-sites.html" />
    <id>tag:www.oncolabinc.com,2009:/blog//1.13</id>

    <published>2009-10-21T17:09:27Z</published>
    <updated>2009-10-27T13:00:54Z</updated>

    <summary><![CDATA[Oncolab is pleased to announce that AnyLabTestNow franchise locations now have the chance to become official draw sites for the AMAS test.&nbsp; As locations are signed up their contact information will be placed into the Lab and Doctor maps found...]]></summary>
    <author>
        <name>Paul Navitsky</name>
        <uri>http://www.oncolabinc.com</uri>
    </author>
    
        <category term="News" scheme="http://www.sixapart.com/ns/types#category" />
    
    
    <content type="html" xml:lang="en-US" xml:base="http://www.oncolabinc.com/blog/">
        <![CDATA[Oncolab is pleased to announce that AnyLabTestNow franchise locations now have the chance to become official draw sites for the AMAS test.&nbsp; As locations are signed up their contact information will be placed into the Lab and Doctor maps found <a href="http://www.oncolabinc.com/map.php">Here.</a>&nbsp; This is a great opportunity for AnyLabTestNow locations, Oncolab and most importantly for patients wanting to run the AMAS test.&nbsp; Our goal is to make the process of taking the AMAS test as easy as possible and this is another step in that direction.<br /><br /><a href="http://www.anylabtestnow.com/">AnyLabTestNow</a><br /><br /> <div><br /></div>]]>
        
    </content>
</entry>

<entry>
    <title>AMAS Test Endorsement</title>
    <link rel="alternate" type="text/html" href="http://www.oncolabinc.com/blog/2009/10/doctor-endorsement-for-the-amas-test-1.html" />
    <id>tag:www.oncolabinc.com,2009:/blog//1.12</id>

    <published>2009-10-09T14:45:35Z</published>
    <updated>2009-10-15T18:07:37Z</updated>

    <summary>Margaret Rank, M.D. &quot;The AMAS test is a powerful diagnostic and prognostic tool when used properly. Measuring the levels of antibodies to Malignin, it can be used to diagnose sub-clinical cancer. That is, it can detect very small tumors before...</summary>
    <author>
        <name>Paul Navitsky</name>
        <uri>http://www.oncolabinc.com</uri>
    </author>
    
        <category term="General information" scheme="http://www.sixapart.com/ns/types#category" />
    
    
    <content type="html" xml:lang="en-US" xml:base="http://www.oncolabinc.com/blog/">
        <![CDATA[<h2>Margaret Rank, M.D.</h2>
					<p>"The AMAS test is a powerful diagnostic and prognostic tool when used
properly. Measuring the levels of antibodies to Malignin, it can be
used to diagnose sub-clinical cancer. That is, it can detect very
small tumors before they become evident by usual diagnostic tests and
physical exam. Small cancers can often be treated for cure with either
conventional means or natural means. This is truly one of the weapons
against cancer that is grossly underutilized.<br />
						<br /></p> ]]>
        <![CDATA[<br />
						Use of the AMAS can prevent unnecessary procedures or prompt further
investigation. For instance, statistics show that up to nine of 10
biopsies done because of an "abnormal" mammogram, are done for
non-cancerous lesions. Also, many of the pathology reports of breast
biopsies read as cancerous actually represent benign (non-cancerous)
conditions. If the AMAS were used in these cases, many unnecessary,
anxiety provoking surgical procedures could be avoided. Additionally,
misdiagnoses of breast cancer that often lead to chemotherapy and
radiation treatment, could be avoided in many cases. The mammogram is
far too sensitive (it detects "disease" frequently when there is
none), very non-specific (it can't always separate benign from
malignant disease) and can deal a potentially cancer-causing dose of
radiation. I have replaced this by breast MRI and/or the AMAS test. I
have helped many of my patients avoid unnecessary surgery or biopsies
with judicious use of this test.<br /><br />
						The AMAS, in conjunction with other clinical studies including
assessment of the immune system, can help follow the progress of
treatment or the need for intensification of therapy when dealing with
a known cancer. It also assists with prognosis, detection of tumor
progression or regression, and efficacy of a particular treatment
protocol.
						<br /><br />
						
						To patients, I suggest strongly that they find a competent clinician
familiar with the AMAS test and its interpretation to assess their
individual needs and guide them in their decision-making."<br />
						<br />
						Margaret Rank, M.D.<br />
						Melbourne, FL]]>
    </content>
</entry>

<entry>
    <title>Doctor Endorsement for the AMAS Test</title>
    <link rel="alternate" type="text/html" href="http://www.oncolabinc.com/blog/2009/10/doctor-endorsement-for-the-amas-test.html" />
    <id>tag:www.oncolabinc.com,2009:/blog//1.11</id>

    <published>2009-10-09T14:39:05Z</published>
    <updated>2009-10-13T12:31:32Z</updated>

    <summary>Carol Ann Ryser, M.D. &quot;I believe that people with high risk in their family of cancer, or people over 45 or 50 should definitely take the test. People over 45 or 50 should be screened with the AMAS Test in...</summary>
    <author>
        <name>Paul Navitsky</name>
        <uri>http://www.oncolabinc.com</uri>
    </author>
    
    
    <content type="html" xml:lang="en-US" xml:base="http://www.oncolabinc.com/blog/">
        <![CDATA[<h2>Carol Ann Ryser, M.D.</h2>
					<p>"I believe that people with high
risk in their family of cancer, or people over 45 or 50 should
definitely take the test. People over 45 or 50 should be screened with
the AMAS Test in the same way people receive routine mammographies and
other kinds of tests including the PSA. I think the AMAS Test should
be included."<br />
						<br /><br /></p> ]]>
        <![CDATA[<span class="Apple-style-span" style="color: rgb(0, 0, 0); font-family: Times; font-size: medium; "><div style="margin-top: 0px; margin-right: 0px; margin-bottom: 0px; margin-left: 0px; padding-top: 10px; padding-right: 10px; padding-bottom: 10px; padding-left: 10px; height: 90%; border-top-width: 0px; border-right-width: 0px; border-bottom-width: 0px; border-left-width: 0px; border-style: initial; border-color: initial; background-image: initial; background-repeat: initial; background-attachment: initial; -webkit-background-clip: initial; -webkit-background-origin: initial; background-color: rgb(255, 255, 255); color: rgb(51, 51, 51); font: normal normal normal 13px/normal arial, helvetica, hirakakupro-w3, osaka, 'ms pgothic', sans-serif; background-position: initial initial; "><h2 style="margin-top: 0px; margin-right: 0px; margin-bottom: 0.75em; margin-left: 0px; border-top-width: 0px; border-right-width: 0px; border-bottom-width: 0px; border-left-width: 0px; border-style: initial; border-color: initial; padding-top: 0px; padding-right: 0px; padding-bottom: 0px; padding-left: 0px; font-size: 1.5em; font-weight: normal; ">Carol Ann Ryser, M.D.</h2><p style="margin-top: 0px; margin-right: 0px; margin-bottom: 0.75em; margin-left: 0px; border-top-width: 0px; border-right-width: 0px; border-bottom-width: 0px; border-left-width: 0px; border-style: initial; border-color: initial; padding-top: 0px; padding-right: 0px; padding-bottom: 0px; padding-left: 0px; font-size: 1em; font-weight: normal; ">"I believe that people with high risk in their family of cancer, or people over 45 or 50 should definitely take the test. People over 45 or 50 should be screened with the AMAS Test in the same way people receive routine mammographies and other kinds of tests including the PSA. I think the AMAS Test should be included.<br /><br />In my practice I've also used this test effectively in patients with clinical symptoms that are not clear: i.e . vague clinical symptoms. To give you a short example a 35 year old woman was having pelvic pain and she had just delivered a baby. She had seen several physicians. They diagnosed here with irritable bowel but they didn't know what was going on, so she came to see me. I did the AMAS because the pain was getting more severe and more intense for her and no one could see anything. The AMAS TEST was positive. So I called one of my Oncology/Gyn friends and said you have got to look over this lady very carefully. There is something going on in her pelvis. Amazingly they found a small malignant tumor at the junction of the cervix and the vaginal wall -a very small little knot. They took it out. The pain went away. Her AMAS came back to normal after three or four months and that was two or three years ago and she's been healthy ever since. It was a malignant tumor. It is phenomenal. And of course her family is grateful, three children, and her husband. Most people who come in will have some area in their body they are complaining about. She had focused discomfort and pain- clinical symptoms. When you zero in on that area first and then you expand to other general evaluations, you usually are able to find the source of the problem. This a classic example where a young lady would have probably developed severe cancer over the next two years. It was exciting to find the cancer early.<br /><br />I rely on colleagues in the relevant areas of specialty to explore the lung, the breast. They do their part of the evaluation. I use the AMAS Test with my patients as part of the total review which includes family history, personal history, physicians review. I use all of the diagnostic tests together."<br /><br />Carol Ann Ryser, M.D.<br />Kansas City, MO</p></div></span>]]>
    </content>
</entry>

<entry>
    <title>Breast Cancer Genetic Evolution Decoded </title>
    <link rel="alternate" type="text/html" href="http://www.oncolabinc.com/blog/2009/10/breast-cancer-genetic-evolution-decoded.html" />
    <id>tag:www.oncolabinc.com,2009:/blog//1.10</id>

    <published>2009-10-09T13:34:43Z</published>
    <updated>2009-10-09T13:38:07Z</updated>

    <summary>In what they called a &quot;watershed event,&quot; Canadian researchers reported that the genetic code of breast cancer evolves over time, a finding they said might lead to more targeted treatments. The researchers, using cutting edge gene sequencing technology... full story...</summary>
    <author>
        <name>Ron Snow</name>
        <uri>http://oncolabinc.com</uri>
    </author>
    
    <category term="amas" label="AMAS" scheme="http://www.sixapart.com/ns/types#tag" />
    <category term="breastcancer" label="Breast Cancer" scheme="http://www.sixapart.com/ns/types#tag" />
    <category term="geneticcodeofbreastcancer" label="genetic code of breast cancer" scheme="http://www.sixapart.com/ns/types#tag" />
    <category term="targetedtreatment" label="targeted treatment" scheme="http://www.sixapart.com/ns/types#tag" />
    
    <content type="html" xml:lang="en-US" xml:base="http://www.oncolabinc.com/blog/">
        <![CDATA[<span class="excerpt" style="FONT-SIZE: 12px; LINE-HEIGHT: 14px; FONT-FAMILY: arial; TEXT-ALIGN: left">In what they called a "watershed event," Canadian researchers reported that the genetic code of breast cancer evolves over time, a finding they said might lead to more targeted treatments. The researchers, using cutting edge gene sequencing technology...</span> <span class="full-link"><a style="FONT-SIZE: 11px; COLOR: #c75434; FONT-STYLE: italic" href="http://www.medpagetoday.com/HematologyOncology/BreastCancer/tb/16347?userid=217930&amp;impressionId=1255067765398&amp;utm_source=mSpoke&amp;utm_medium=email&amp;utm_campaign=DailyHeadlines&amp;utm_content=Group1">full story</a></span> ]]>
        
    </content>
</entry>

<entry>
    <title>ASCO Breast: Most Deaths Fall Outside Screening Programs (CME/CE)</title>
    <link rel="alternate" type="text/html" href="http://www.oncolabinc.com/blog/2009/10/asco-breast-most-deaths-fall-outside-screening-programs-cmece.html" />
    <id>tag:www.oncolabinc.com,2009:/blog//1.9</id>

    <published>2009-10-08T13:42:27Z</published>
    <updated>2009-10-08T13:44:52Z</updated>

    <summary>SAN FRANCISCO -- Nearly three-quarters of breast cancer deaths occur among women who don&apos;t get regular screening mammograms, according to a large population-based study. Breast cancer mortality rates extrapolated from the findings were just 4.7% for... full story...</summary>
    <author>
        <name>Ron Snow</name>
        <uri>http://oncolabinc.com</uri>
    </author>
    
    <category term="amas" label="AMAS" scheme="http://www.sixapart.com/ns/types#tag" />
    <category term="breastcancer" label="Breast Cancer" scheme="http://www.sixapart.com/ns/types#tag" />
    <category term="earlydetection" label="early detection" scheme="http://www.sixapart.com/ns/types#tag" />
    <category term="regularscreening" label="regular screening" scheme="http://www.sixapart.com/ns/types#tag" />
    
    <content type="html" xml:lang="en-US" xml:base="http://www.oncolabinc.com/blog/">
        <![CDATA[<span class="excerpt" style="FONT-SIZE: 12px; LINE-HEIGHT: 14px; FONT-FAMILY: arial; TEXT-ALIGN: left">SAN FRANCISCO -- Nearly three-quarters of breast cancer deaths occur among women who don't get regular screening mammograms, according to a large population-based study. Breast cancer mortality rates extrapolated from the findings were just 4.7% for...</span> <span class="full-link"><a style="FONT-SIZE: 11px; COLOR: #c75434; FONT-STYLE: italic" href="http://www.medpagetoday.com/MeetingCoverage/ASCOBreast/tb/16320?userid=217930&amp;impressionId=1254981826110&amp;utm_source=mSpoke&amp;utm_medium=email&amp;utm_campaign=DailyHeadlines&amp;utm_content=Group1">full story</a></span> ]]>
        
    </content>
</entry>

</feed>
